IRON logo

IRON Disc Medicine, Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$75.14
-0.97 (-1.27%)

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by pr…

Market Cap: $2.88Bwww.discmedicine.com

Price

$77.44+17.42%
$64.07$69.40$74.73$80.06
Apr 30Aug 7

Social Signal Score

46
5d
50
1 mentions
+0.0%
30d
50
3 mentions
+0.0%
60d
40
12 mentions
+0.0%
90d
42
15 mentions
+0.0%
news: 15

Analyst Ratings

11 analysts
Buyconsensus
Strong Buy 1Buy 10Hold 0Sell 0Strong Sell 0
Avg price target$127.14+69.2%
Low $92Median $120High $170
Current Consensus

Revenue

$0.00
$0.00
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-6.00
$-6.18–$-5.82
11 analysts
FY2026
$-5.90
$-6.07–$-5.80
9 analysts
FY2027
$-5.95
$-7.17–$-5.17
9 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
John D. Quisel
Sector
Healthcare
Industry
Biotechnology
Employees
165
Beta
2.01
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
16.80
www.discmedicine.com